PAR-26-040: Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

PAR-26-040 invites research teams to lead transformational advances in bioinformatics, translational bioinformatics, and computational biology. This opportunity from the National Library of Medicine (NLM) supports projects that create cutting-edge methods, tools, and computational approaches for extracting actionable knowledge from complex biological and biomedical data. Applications open April 6, 2026 and follow NIH standard due dates (first due June 5, 2026). This initiative supports scalable, generalizable innovations that accelerate biomedical discovery and improve health outcomes.

How much funding would I receive?

• Direct cost limit: Up to $250,000 per year (applicants must justify budget based on project needs).

• Anticipated total program funding: Approximately $2,500,000.

• Estimated number of awards: 10.

What could I use the funding for?

Fund research projects that:

• Develop new computational methods and tools for bioinformatics and biomedical data science.

• Leverage AI, machine learning, and large-scale computation to interpret diverse biological datasets.

• Produce durable, generalizable artifacts (software, workflows, resources) that benefit the wider research community.

• Enable translational insights with potential impact on health outcomes.

Excluded: incremental tweaks to existing tools, projects outside core bioinformatics/computational biology focus, social/ethical studies unrelated to computational method advancement.

Are there any additional benefits I would receive?

• Projects are expected to produce open science outputs (e.g., FAIR tools, publicly available code, datasets).

• Participation in NIH peer review and community of biomedical informatics researchers.

What is the timeline to apply and when would I receive funding?

• Standard NIH due dates: June 5, October 5, February 5 recurring through 2029 (all due by 5:00 PM local time of the applicant).

• NOFO expiration date: March 6, 2029.

• Earliest possible project start: July 2026.

Where does this funding come from?

This opportunity is funded by the U.S. Department of Health and Human Services (HHS) through the National Institutes of Health (NIH), specifically the National Library of Medicine (NLM).

Who is eligible to apply?

Eligible applicants include:

• Higher education institutions (public and private).

• Nonprofits (with or without 501(c)(3) status).

• For-profit organizations, including small businesses.

• Local and state governments.

• Tribal governments and organizations.

• Foreign organizations (subject to NIH policies).

Important NIH policy: NIH will not issue awards for applications that include foreign subawards or subcontracts unless submitted to a NOFO specifically for international collaborations.

What companies and projects are likely to win?

Competitive applications will:

• Demonstrate high innovation and impact in computational biology/bioinformatics.

• Deliver tools and methods that are publicly accessible and broadly usable.

• Show rigorous validation and clear plans for dissemination.

• Integrate interdisciplinary approaches and emphasize scalability.

Are there any restrictions I should know about?

• Foreign subawards/subcontracts are not allowed (projects with those elements will be noncompliant).

• Cost sharing/matching is not required.

• The project must align with NLM’s focus areas; non-responsive or tangential projects will not be reviewed.

How long will it take me to prepare an application?

Preparation time varies by complexity, but obtaining organizational registrations (SAM, eRA Commons) alone can take several weeks. Technical application drafting with rigorous computational research plans, data management strategy, and dissemination plans typically requires multiple months of coordinated effort.

How can BW&CO help?

BW&CO can:

• Translate scientific aims into NIH-aligned application narratives.

• Help articulate innovation, significance, and approach clearly.

• Build budget justification and milestone plans that meet NIH expectations.

• Develop data management, dissemination, and impact strategies that strengthen score.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements for submitting application ($13,000) available.

Additional Resources

Review the solicitation here.

PAR-26-042: Research Grants in Clinical Informatics (R01 Clinical Trial Optional)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

This funding opportunity from the National Library of Medicine (NLM) at NIH supports investigator-initiated research grants in clinical informatics that develop innovative, generalizable methods and tools to transform complex health data into actionable knowledge and improve decision-making and health outcomes. Applications must be submitted by 5:00 PM local time on one of the standard NIH due dates (next dates include June 5, 2026; October 5, 2026; February 5, 2027, etc.) and the NOFO remains active until its expiration on March 6, 2029.

How much funding would I receive?

• Direct cost limit: Up to $250,000 per year (applicants must justify budget based on project needs).

• Anticipated total program funding: Approximately $2,500,000.

• Estimated number of awards: 10.

What could I use the funding for?

Fund research focused on the design, implementation, and evaluation of clinical informatics tools and methods that:

• Enable data-driven discovery and evidence-based decision-making.

• Transform raw, heterogeneous health data (e.g., EHRs, clinical notes, imaging, patient-generated data) into usable knowledge.

• Produce scalable, reproducible, domain-independent approaches broadly applicable across clinical settings.

• Improve clinical workflows, predictive analytics, decision support, interoperability, and precision health.

Are there any additional benefits I would receive?

• Potential to accelerate scientific insights and inform future research beyond the project period.

• Alignment with NLM’s mission to advance data-driven biomedical research and healthcare.

• Software, datasets, methods, and resources are expected to be disseminated widely to maximize impact.

What is the timeline to apply and when would I receive funding?

• Standard NIH due dates: June 5, October 5, February 5 recurring through 2029 (all due by 5:00 PM local time of the applicant).

• NOFO expiration date: March 6, 2029.

• Earliest possible project start: July 2026.

Where does this funding come from?

This opportunity is funded by the U.S. Department of Health and Human Services (HHS) through the National Institutes of Health (NIH), specifically the National Library of Medicine (NLM).

Who is eligible to apply?

Eligible applicants include:

• Higher education institutions (public and private).

• Nonprofits (with or without 501(c)(3) status).

• For-profit organizations, including small businesses.

• Local and state governments.

• Tribal governments and organizations.

• Foreign organizations (subject to NIH policies).

Important NIH policy: NIH will not issue awards for applications that include foreign subawards or subcontracts unless submitted to a NOFO specifically for international collaborations.

What companies and projects are likely to win?

Competitive applications will:

• Address transformative clinical informatics challenges and align tightly with NLM goals.

• Demonstrate innovation, scalability, and generalizability beyond narrow disease-specific problems.

• Provide clear plans for evaluation, dissemination, and sustainability of tools and methods.

• Present metrics for impact and comparison to existing approaches.

Are there any restrictions I should know about?

• Projects must be clearly focused on clinical informatics and not be incremental improvements of existing tools.

• Projects primarily focused on social determinants of health or ethical/legal/social issues are considered non-responsive.

• Applications with foreign subawards/subcontracts are noncompliant and will not be reviewed.

How long will it take me to prepare an application?

Preparation time depends on your readiness, but NIH typically recommends starting months before the nearest due date to:

• Complete registrations (Grants.gov, eRA Commons, SAM/NCAGE, UEI).

• Develop a rigorous research plan with evaluation and dissemination strategies.

• Coordinate any institutional approvals.

Begin ASAP to ensure you meet the due date’s 5:00 PM local time deadline.

How can BW&CO help?

BW&CO can:

• Translate scientific aims into NIH-aligned application narratives.

• Help articulate innovation, significance, and approach clearly.

• Build budget justification and milestone plans that meet NIH expectations.

• Develop data management, dissemination, and impact strategies that strengthen score.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements for submitting application ($13,000) available.

Additional Resources

Review the solicitation here.

ARPA-H - Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Advanced Research Projects Agency for Health (ARPA-H), Resilient Systems Office (RSO), has released an Innovative Solutions Opening (ISO) for the Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) (Solicitation Number: ARPA-H-SOL-26-139, Amendment 1).

CIRCLE seeks to reduce ICU stay length and improve outcomes by developing integrated systems that:

• Measure tissue-specific immuno-inflammatory biomarkers in near real time

• Build mechanistic, patient-specific computational “digital twin” models

• Modulate immune dysfunction using personalized therapeutic interventions

The program aims for a 25% reduction in average ICU stay length and progression toward FDA-compliant systems and clinical adoption.

Solution Summaries are due March 30th.

How much funding would I receive?

The solicitation states that multiple awards are anticipated.

• Awards will be made as Other Transaction (OT) agreements.

• The number of awards will depend on the quality of proposals and the availability of funds.

• Individual award amounts are not specified in the solicitation.

• Cost share requirements are not specified in the solicitation.

ARPA-H reserves the right to:

• Fund proposals in phases

• Segregate portions into pre-priced options

• Make partial awards

• Make no awards at all

What could I use the funding for?

Funding supports the integrated development of a Measure–Model–Modulate system for critical illness, including:

TA1 – Measurement

• Biomarker discovery and validation

• Tissue-specific immune monitoring technologies

• Data generation suitable for mechanistic modeling

TA2 – Modeling

• Mechanistic computational digital twin models

• In silico clinical trials

• FDA-compliant digital twin platforms

TA3 – Modulation

• Repurposing FDA-approved immunomodulatory therapies

• Development of novel immune-modulating approaches (if justified)

• Pre-clinical and clinical validation

Associate Performers (AP1, AP2, AP3)

• Data infrastructure and standards (AP1)

• Regulatory-compliant digital twin validation environment (AP2)

• ICU-realistic validation infrastructure and clinical trial support (AP3)

Projects must focus on immuno-inflammatory mechanisms common across critical illness and integrate into ICU workflows.

Are there any additional benefits I would receive?

CIRCLE performers will receive:

• Access to ARPA-H resources supporting regulatory approval

• Access to clinical trial consortia to accelerate FDA approvals

• Integration into a shared CIRCLE database that will ultimately become a public resource

• Structured cross-team collaboration across TAs and APs

• Government Purpose Rights (GPR) for certain deliverables

• Potential flexible IP treatment for commercially sensitive technologies (with approval)

Open-source development is highly encouraged using permissive licenses (e.g., CC-BY, BSD, MIT, Apache 2.0).

What is the timeline to apply and when would I receive funding?

Key deadlines (Eastern Time):

• Proposers’ Day: Wednesday, March 11, 2026

• Solution summary submission: Monday, March 30, 2026, 1:00 PM

• Questions & Answers (Q&A) submission: Friday, May 22, 2026, 1:00 PM

• Proposal submission: Thursday, May 28, 2026, 1:00 PM

Deadlines will be strictly enforced.

Period of Performance

The program includes milestones extending up to 5 years from award date, including:

• 3 months: Coordination plans and metric establishment

• 6 months: Research plan finalization and approvals

• 1–3 years: Model development, calibration, validation

• 4–5 years: Integrated system validation and first-in-human adaptive platform trial

Funding timing after selection is not specified in the solicitation.

Where does this funding come from?

Funding comes from:

• Advanced Research Projects Agency for Health (ARPA-H)

• Resilient Systems Office (RSO)

Solicitation Number: ARPA-H-SOL-26-139 (Amendment 1)

Awards will be issued as Other Transaction (OT) agreements.

Who is eligible to apply?

Eligible proposers include:

• Universities

• Non-profit organizations

• Small businesses

• Other than small businesses

FFRDCs and U.S. Government entities:

• May not respond as prime or sub-performers

• May engage with ARPA-H separately under specific conditions

Non-U.S. entities:

• May participate if compliant with applicable laws and regulations

• Awards will not be made to entities organized under the laws of a covered foreign country, foreign entities of concern (per CHIPS and Science Act), or individuals involved in a Malign Foreign Talent Recruitment Program.

All proposers must disclose Organizational Conflicts of Interest (OCI).

What companies and projects are likely to win?

Selectable proposals will:

• Directly address CIRCLE’s goals and objectives

• Integrate measurement, modeling, and modulation components

• Present realistic commercialization plans (for TA proposals)

• Demonstrate regulatory strategy and transition planning

• Provide strong interdisciplinary integration

• Include complete and realistic budgets

Proposals are evaluated individually (not comparatively) based solely on published evaluation criteria.

Budgets that are unrealistically high will be viewed unfavorably.

Are there any restrictions I should know about?

Key restrictions include:

• Funding cannot be used for human subjects research until all approvals are granted.

• Animal research requires IACUC approval prior to incurring costs.

• Performers must comply with federal human subjects and animal welfare regulations.

• Certain software and system components must be delivered with Government Purpose Rights.

• ARPA-H may impose publication restrictions if research involves sensitive information.

• All APIs must use open standards (e.g., REST, JSON, JSON-LD) unless otherwise approved.

• Existing data standards (e.g., HL7, FHIR, DICOM, LOINC, SNOMED CT) must be used where applicable.

Non-conforming proposals may be rejected without further review.

How long will it take me to prepare an application?

The solicitation warns that parts of the submission process may take from one business day to one month to complete.

Given the complexity of:

• Multi-TA integration

• Regulatory planning

• Data standards compliance

• Commercialization strategy

• Cross-team coordination

Companies should expect a significant preparation effort. The exact preparation time will depend on team readiness and prior integration planning.

How can BW&CO help?

BW&CO can support you by:

• Structuring your technical narrative around the Measure–Model–Modulate framework

• Stress-testing alignment with evaluation criteria

• Translating complex science into a fundable ARPA-H narrative

• Designing commercialization and transition strategies

• Supporting budget justification and value positioning

• Coordinating multi-institutional team structures

• Preparing for OT negotiation

CIRCLE is a systems-level, high-integration program. Positioning and coherence across TAs and AP interfaces will be critical.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements for submitting the Solution Summary ($7,500) available.

Additional Resources

Review the solicitation here.

CDMRP: Lupus Research Program (LRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The CDMRP’s FY26 Lupus Research Program (LRP) pre-announcement signals anticipated funding opportunities supporting innovative, high-impact lupus research aimed at understanding, preventing, diagnosing, and treating lupus, as well as improving the quality of life for individuals living with lupus. This pre-announcement does not include application deadlines or guarantee funding — the official Funding Opportunity Announcements (FOAs) will be posted on Grants.gov with formal deadlines and requirements. Investigators should begin planning now to align with expected FY26 mechanisms and program goals.

How much funding would I receive?

The pre-announcement outlines multiple award mechanisms with specified maximum total costs:

• Idea Award – up to $300,000 (2 years)

• Impact Award – up to $1,000,000 (4 years)

• Transformative Vision Development Award – up to $250,000 (2 years)

• Transformative Vision Award – up to $2,000,000 (4 years)

What could I use the funding for?

Funding must support research aligned with one or more LRP focus areas:

Biological & Clinical Research

• Mechanisms of lupus disease and pathobiology

• Genetic, epigenetic, and gene–environment interaction studies

• Disease heterogeneity, presentations, and outcomes
  Applies to Idea & Impact Awards

Quality of Life & Intervention Studies

• Addressing social determinants of health

• Nutrition, symptom control, comparative effectiveness

• Outcomes research and patient-reported outcomes
  Applies to Impact, Transformative Vision Development, and Transformative Vision Awards

Innovative Health Care Delivery Models

• Models improving lupus outcomes
  Applies to Impact, Transformative Vision Development, and Transformative Vision Awards

Are there any additional benefits I would receive?

• Mechanism clarity ahead of FOAs allows early planning.

• Subscribe to email updates through eBRAP for timely notifications when FOAs are released.

• Being positioned early can improve competitiveness.

What is the timeline to apply and when would I receive funding?

• Pre-announcement released: February 11, 2026.

• Formal FOAs — will be posted on Grants.gov with official pre-application and full application deadlines.

• Investigators must submit a pre-application through eBRAP prior to the pre-application deadline specified in the FOAs.

Where does this funding come from?

Funding is provided through the FY26 Defense Appropriations Act appropriated to the Congressionally Directed Medical Research Programs (CDMRP) and managed by the Defense Health Agency Research & Development and Medical Research and Development Command (DHA R&D-MRDC).

Who is eligible to apply?

Eligibility is defined by mechanism:

• Idea Award: Investigators at or above postdoctoral level.

• Impact & Transformative Awards: Investigators at or above Assistant Professor (or equivalent).

• Team Requirements: Transformative mechanisms must include at least one lupus consumer advocate as part of the research team.

What companies and projects are likely to win?

Projects that:

• Align tightly with the specified focus areas.

• Demonstrate high innovation and impact potential.

• Involve strong preliminary data (as required for Transformative Vision Award).

• Include meaningful involvement of lupus consumer advocates (for transformative mechanisms).

Are there any restrictions I should know about?

• This pre-announcement is not a funding commitment; only the FOAs establish requirements and obligations.

• Applications cannot support clinical trials in Idea or Impact Awards; Transformative Vision Awards may support clinical trials but not animal studies.

• Transformative Vision Development Awards cannot support clinical trials or animal studies.

How long will it take me to prepare an application?

Preparation time depends on mechanism and complexity, but begin planning now — especially for pilot data and consumer engagement for transformative mechanisms. Historically, competitive CDMRP applications often require several weeks to months of focused preparation.

How can BW&CO help?

BW&CO can:

• Develop alignment narratives tied to LRP focus areas.

• Assist with preliminary data framing and research strategy articulation.

• Craft strong consumer advocacy integration plans.

• Ensure conformity with CDMRP review criteria once FOAs are released.

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.